NUVB FY 2020 Earnings — Nuvation Bio Inc. Revenue & Financial Results | Market Cap Arena

NUVBNuvation Bio Inc.

$2B

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$103,000

Operating Income

-$44M

Net Income

-$42M

EPS (Diluted)

$-0.19

Cash Flow

Operating Cash Flow

-$37M

Free Cash Flow

-$37M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$222M

Total Liabilities

$7M

Stockholders' Equity

$215M

Cash & Equivalents

$30M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$103,000	$0	—
Operating Income	-$44M	-$32M	-35.7%
Net Income	-$42M	-$34M	-24.2%